HCPCS Level IIdrugActive
J9173
Inj., durvalumab, 10 mg
BETOS: O1E
Effective: 2019-01-01
Description
Injection, durvalumab, 10 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Imfinzi
Manufacturer
AstraZeneca Pharmaceuticals LP
HCPCS Dosage
10 MG
Billing Units
12.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.